PAR 4.65% 22.5¢ paradigm biopharmaceuticals limited..

General OA media and info, page-217

  1. 3,755 Posts.
    lightbulb Created with Sketch. 104
    Today in my Facebook feed, I received a request to participate in a Sydney University based study to investigate the "efficacy and safety of oral Sodium Pentosan Polysulphate compared to a placebo in participants with symptomatic knee osteoarthritis (OA) and dyslipidemia".

    They are looking for 92 participants who can visit Royal North Shore Hospital four times in 6 months and Castlereagh Imaging (for two MRI scans). I'll be travelling soon and cannot participate and wonder if anyone has heard about this study or know more about it?

    Apologies if this has been covered elsewhere.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.010(4.65%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 23.5¢ 21.5¢ $288.5K 1.279M

Buyers (Bids)

No. Vol. Price($)
6 130626 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 60000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.